Total and Specific IgE

← Back to Lab Reference Library

Category: Inflammation and Immune  |  Also known as: Immunoglobulin E, Total IgE, Allergen-Specific IgE, RAST  |  Sample: Serum (fasting not required)

1. What This Test Measures

Immunoglobulin E (IgE) is the antibody class responsible for type I immediate hypersensitivity reactions, the classical allergic response. IgE is produced by B cells in response to allergen exposure and circulates at the lowest concentration of any immunoglobulin class (typically less than 0.001% of total serum immunoglobulins). Despite its low concentration, IgE has profound biological potency because of its high-affinity binding to FcepsilonRI receptors on mast cells and basophils. When an allergen cross-links two IgE molecules on a mast cell surface, the mast cell degranulates, releasing histamine, prostaglandins, leukotrienes, and cytokines that produce the clinical allergic response.

Total IgE measures the sum of all IgE molecules in the blood, regardless of their allergen specificity. It reflects the overall magnitude of IgE-mediated immune activation. Specific IgE (historically called RAST, radioallergosorbent test; now performed by immunoassay methods such as ImmunoCAP) measures IgE antibodies directed against one particular allergen: a specific food (peanut, milk, egg, wheat), an inhalant (dust mite, cat dander, grass pollen, mold), a venom (bee, wasp), or a medication (penicillin).

The two measurements provide complementary information. Total IgE tells you the volume of allergic immune activation: is the patient's immune system producing excessive IgE overall? Specific IgE tells you the target: which allergens have the patient's immune system recognized and mounted an IgE response against? A patient with an elevated total IgE of 450 IU/mL and high specific IgE to dust mite, cat, and grass pollen has a clear allergic sensitization pattern driving their symptoms. A patient with an elevated total IgE of 800 IU/mL with no identifiable specific allergen sensitization requires evaluation for parasitic infection, atopic dermatitis, allergic bronchopulmonary aspergillosis (ABPA), or hyper-IgE syndrome.

2. Why This Test Matters

• Allergic disease confirmation: specific IgE provides objective evidence of allergic sensitization to individual allergens. This replaces guesswork and elimination diets with measurable, allergen-specific data that guides avoidance strategies and immunotherapy decisions
• Allergy vs MCAS distinction: this is one of the most clinically important applications of IgE testing. True IgE-mediated allergy involves allergen-specific IgE triggering mast cells through the FcepsilonRI pathway. MCAS involves inappropriate mast cell activation through non-IgE mechanisms. In allergy, specific IgE to the triggering allergen is positive. In MCAS, specific IgE is typically negative for the triggers that provoke symptoms because the triggers are not allergens. Normal total IgE with mast cell activation symptoms points toward MCAS rather than allergy
• Anaphylaxis risk assessment: the level of specific IgE to a food or venom allergen correlates with the probability of clinical reactivity on exposure. Higher specific IgE levels indicate higher risk of anaphylaxis, guiding the urgency of avoidance strategies and epinephrine auto-injector prescription
• Immunotherapy candidacy: allergen immunotherapy (subcutaneous or sublingual) is indicated for IgE-mediated allergies where avoidance is impractical. Specific IgE identifies which allergens to include in the immunotherapy formulation
• Asthma phenotyping: allergic (eosinophilic) asthma is characterized by elevated total IgE and specific IgE to inhalant allergens. This phenotype responds to anti-IgE therapy (omalizumab) and allergen avoidance. Non-allergic asthma has normal IgE and requires different treatment strategies
• Parasitic infection screening: markedly elevated total IgE (above 500 to 1000 IU/mL) with no identifiable allergen sensitization raises suspicion for parasitic (helminth) infection, which stimulates potent polyclonal IgE production
• Atopic dermatitis severity: total IgE correlates with atopic dermatitis severity and helps distinguish intrinsic (non-IgE) from extrinsic (IgE-associated) atopic dermatitis phenotypes

3. Standard Lab Reference Range

Measurement	Reference Range	Clinical Notes
Total IgE (adults)	Below 100 IU/mL	Values above 100 suggest atopic predisposition; above 200 strongly associated with allergic disease
Total IgE (children)	Age-dependent (rises through childhood)	Lower in infancy, increases through adolescence, stabilizes in adulthood
Specific IgE Class 0	Below 0.35 kUA/L	Negative: no sensitization detected to the tested allergen
Specific IgE Class 1	0.35 to 0.70 kUA/L	Low positive: equivocal clinical significance; may or may not produce symptoms on exposure
Specific IgE Class 2 to 3	0.70 to 17.50 kUA/L	Moderate to strong positive: likely clinically relevant; high probability of symptoms on exposure
Specific IgE Class 4 to 6	Above 17.50 kUA/L	Very strong to extreme positive: very high probability of clinical reactivity; anaphylaxis risk assessment warranted

4. Functional Medicine Interpretation

Pattern	Interpretation	Clinical Direction
Elevated total IgE + positive specific IgE	IgE-mediated allergy confirmed; specific allergens identified	Allergen avoidance, immunotherapy candidacy evaluation, mast cell stabilization for symptom control
Normal total IgE + positive specific IgE	Sensitization to specific allergens with low overall allergic burden	Targeted avoidance; may not need systemic allergy management
Elevated total IgE + negative specific IgE panel	Polyclonal IgE elevation without identified allergen target	Evaluate for parasites, atopic dermatitis, ABPA, hyper-IgE syndrome, or mastocytosis
Normal total IgE + mast cell symptoms	Non-IgE mast cell activation (MCAS likely)	Mast cell mediator panel: tryptase, N-methylhistamine, PGD2 metabolite

5. IgE in the Complete Immune and Allergy Panel

Marker	What It Adds	When to Use
Total and Specific IgE (this page)	Allergic sensitization; IgE-mediated vs non-IgE distinction	Allergy evaluation; MCAS workup context
Serum Tryptase	Mast cell number (baseline) and degranulation (acute)	MCAS/mastocytosis evaluation
hs-CRP	Systemic inflammation; chronic allergic inflammation contributes	Baseline inflammation assessment
Eosinophil Count (CBC)	Eosinophilic inflammation; correlates with allergic and parasitic disease	Standard CBC differential
Vitamin D	Immune modulation; deficiency associated with increased allergic disease	Baseline in all allergic patients
Cortisol	Adrenal stress response; cortisol modulates IgE and mast cell activity	When stress exacerbates allergic symptoms

6. Symptoms Associated With IgE-Mediated Allergy

7. What Causes Elevated IgE

• Allergic disease (most common): allergic rhinitis, allergic asthma, atopic dermatitis, and food allergy all involve IgE-mediated immune responses. The Th2 immune pathway drives B cell class switching to IgE production in genetically predisposed individuals exposed to environmental allergens
• Parasitic (helminth) infection: helminths (roundworms, hookworms, Strongyloides, Schistosoma) stimulate potent polyclonal IgE production as part of the anti-parasitic immune response. Markedly elevated total IgE (above 500 to 1000 IU/mL) without identified allergen sensitization warrants parasite evaluation, particularly in patients with travel history or eosinophilia
• Atopic dermatitis: intrinsically linked to IgE elevation; extrinsic (IgE-high) atopic dermatitis accounts for approximately 80% of cases and is associated with food sensitization and inhalant allergy
• Allergic bronchopulmonary aspergillosis (ABPA): hypersensitivity reaction to Aspergillus in the airways producing markedly elevated total IgE (often above 1000 IU/mL), specific IgE to Aspergillus, eosinophilia, and pulmonary infiltrates
• Hyper-IgE syndrome (Job syndrome): rare primary immunodeficiency with extremely elevated total IgE (typically above 2000 IU/mL), recurrent staphylococcal skin abscesses, pneumonia, and characteristic facial features
• Intestinal permeability: increased gut permeability allows intact food proteins to cross the intestinal barrier and stimulate IgE production in the gut-associated lymphoid tissue. Gut barrier restoration can reduce food-specific IgE sensitization over time
• Immunodeficiency: selective IgA deficiency paradoxically increases IgE production as a compensatory mechanism, leading to elevated IgE and increased atopic disease prevalence in IgA-deficient patients

8. How to Manage Elevated IgE and Allergic Burden

9. Related Lab Tests

10. When Testing Is Recommended

• Suspected allergic rhinitis, allergic asthma, or atopic dermatitis: specific IgE identifies the triggering allergens and guides avoidance and immunotherapy
• Food allergy evaluation: specific IgE to suspected food allergens provides objective sensitization data (note: food-specific IgE indicates sensitization, not necessarily clinical reactivity; oral food challenge is the gold standard for confirming clinical allergy)
• Anaphylaxis history: specific IgE to suspected triggers (foods, venoms, medications) confirms the allergic mechanism and identifies the causative allergen
• MCAS vs allergy distinction: normal total IgE with mast cell activation symptoms suggests MCAS. Elevated total IgE with positive specific IgE suggests IgE-mediated allergy. Both conditions require mast cell management, but the treatment approach differs
• Markedly elevated eosinophil count: evaluate total IgE to distinguish allergic disease from parasitic infection or eosinophilic GI disease
• Before immunotherapy: specific IgE identifies which allergens to include in the immunotherapy formulation
• Chronic urticaria evaluation: elevated IgE suggests allergic trigger; normal IgE with chronic urticaria suggests autoimmune urticaria or MCAS
• Comprehensive immune evaluation alongside tryptase, hs-CRP, and vitamin D for complete allergic and immune assessment

11. Clinical Perspective

12. Frequently Asked Questions